Overview

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

Status:
RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
Idiopathic pulmonary fibrosis has a poor prognosis with limited treatment options. The Investigator hypothesize hyperpolarized Xe129-MRI can be performed in patients with IPF and repeated over time which will detect deficiencies related to perfusion in the lung.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
University of Virginia